Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Novel molecular targets for the therapy of urothelial cancer
Bagi R.P. Jana, Yan Zhou
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel molecular targets for the therapy of urothelial cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Therapeutic Targets
100%
Urothelial Cancer
100%
Advanced Urothelial Cancer
100%
Molecular Mechanism
50%
Clinical Trials
50%
Standard of Care
50%
Molecular Pathways
50%
Number of Patients
50%
Locally Advanced
50%
Overall Survival
50%
Conventional Chemotherapy
50%
Novel Agents
50%
Medical Issues
50%
Disease-specific Survival
50%
Platinum-based Chemotherapy
50%
Chemotherapy Combinations
50%
Advanced Urothelial Carcinoma
50%
Metastatic Urothelial Cancer
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Molecular Target
100%
Chemotherapy
50%
Clinical Trial
25%
Overall Survival
25%
Transitional Cell Carcinoma
25%
Disease Specific Survival
25%
Medicine and Dentistry
Urothelial Cancer
100%
Clinical Trial
25%
Transitional Cell Carcinoma
25%
Overall Survival
25%
Combination Chemotherapy
25%
Disease Specific Survival
25%